ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
General Health & Fitness
Health & Wellness
FDA Clears 'Recharge-Free' Neurostimulation Device for Chronic Pain
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Nelson Vergel" data-source="post: 159610" data-attributes="member: 3"><p>The US Food and Drug Administration (FDA) has approved Abbott Laboratories' Proclaim XR neurostimulation system for chronic pain patients. The device has a battery life of up to 10 years, the company announced.</p><p></p><p>The Proclaim XR platform uses the company's proprietary low energy BurstDR stimulation waveform coupled with a low dosing protocol to provide effective pain relief with lower doses of stimulation, which significantly extends the system's battery life.</p><p></p><p>"<em>Proclaim XR</em> is a major advancement in <a href="https://emedicine.medscape.com/article/1980819-overview" target="_blank">spinal cord stimulation</a>, and is an evidence-based therapy that is mobile app-based and features upgradeable software. This means patients won't need surgery to benefit from future advances in this technology," </p><p></p><p><a href="https://www.medscape.com/viewarticle/919101?nlid=131803_3901&src=wnl_newsalrt_190927_MSCPEDIT&uac=291811EY&impID=2110879&faf=1" target="_blank">FDA Clears Novel 'Recharge-Free' Device for Chronic Pain</a></p></blockquote><p></p>
[QUOTE="Nelson Vergel, post: 159610, member: 3"] The US Food and Drug Administration (FDA) has approved Abbott Laboratories' Proclaim XR neurostimulation system for chronic pain patients. The device has a battery life of up to 10 years, the company announced. The Proclaim XR platform uses the company's proprietary low energy BurstDR stimulation waveform coupled with a low dosing protocol to provide effective pain relief with lower doses of stimulation, which significantly extends the system's battery life. "[I]Proclaim XR[/I] is a major advancement in [URL='https://emedicine.medscape.com/article/1980819-overview']spinal cord stimulation[/URL], and is an evidence-based therapy that is mobile app-based and features upgradeable software. This means patients won't need surgery to benefit from future advances in this technology," [URL="https://www.medscape.com/viewarticle/919101?nlid=131803_3901&src=wnl_newsalrt_190927_MSCPEDIT&uac=291811EY&impID=2110879&faf=1"]FDA Clears Novel 'Recharge-Free' Device for Chronic Pain[/URL] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
General Health & Fitness
Health & Wellness
FDA Clears 'Recharge-Free' Neurostimulation Device for Chronic Pain
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top